Research Articles | Page 26 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
The Effect of Respiratory Viral Infections on Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria May 2023 International Journal of Molecular Sciences Paroxysmal Nocturnal Hemoglobinuria (PNH)
Young Enough to Undergo Allogeneic Transplantation for Myelodysplastic Syndromes?: Considering the Results of the Medicare Coverage With Evidence Development Study Dec 2019 JAMA Oncology Myelodysplastic Syndromes (MDS)
Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence Sep 2019 JCO Precision Oncology Myelodysplastic Syndromes (MDS)
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantat Feb 2021 Journal for immunotherapy of cancer Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations Dec 2023 Journal of Blood Medicine Paroxysmal Nocturnal Hemoglobinuria (PNH)
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes May 2023 Journal of Clinical Oncology Myelodysplastic Syndromes (MDS)
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes Aug 2024 Journal of Clinical Oncology Myelodysplastic Syndromes (MDS)
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes May 2024 Journal of Clinical Oncology Myelodysplastic Syndromes (MDS)
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS) Oct 2023 Journal of Clinical Oncology Myelodysplastic Syndromes (MDS)
Revisiting Timing and Decision Modeling for Allogeneic Hematopoietic Stem-Cell Transplantation in Myelodysplastic Syndromes Jun 2024 Journal of Clinical Oncology Myelodysplastic Syndromes (MDS)